News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Denies Approval of XenoPort, Inc. (XNPT), GlaxoSmithKline (GSK) RLS Drug; Xenoport


2/18/2010 6:54:03 AM

Bookmark and Share

Reuters -- U.S. regulators have denied approval for a drug from XenoPort (XNPT.O) and GlaxoSmithKline (GSK.L) to treat restless legs syndrome because of a potential link to cancer found in rats.

Read at Reuters
Read at Business Week
Read at Market Watch
Read at Forbes

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES